Renal cell carcinoma: Translational aspects of metabolism and therapeutic consequences

The heterogeneity of renal cell carcinoma (RCC) poses a challenge for designing clinically applicable diagnostic and screening investigations, predictive and prognostic biomarkers, and targeted molecular therapies. Hereditary RCC syndromes harbor specific driver gene mutations, and their discoveries...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, O, Maxwell, P, Pollard, P
Formato: Journal article
Lenguaje:English
Publicado: 2013
_version_ 1826271263983665152
author Yang, O
Maxwell, P
Pollard, P
author_facet Yang, O
Maxwell, P
Pollard, P
author_sort Yang, O
collection OXFORD
description The heterogeneity of renal cell carcinoma (RCC) poses a challenge for designing clinically applicable diagnostic and screening investigations, predictive and prognostic biomarkers, and targeted molecular therapies. Hereditary RCC syndromes harbor specific driver gene mutations, and their discoveries have provided unequivocal insight into the pathogenomic landscape of RCCs. These observed genetic aberrations correspond to a diverse range of dysplastic metabolic processes, including mutations in genes encoding tricarboxylic acid (TCA) cycle enzymes, defects in hypoxic and antioxidant signaling, and abnormalities in nutrient-sensing phosphorylation cascades. Medical management of RCC focused on understanding and correcting these metabolic abnormalities may refine current RCC screening, diagnosis, and treatment. This review describes RCC subtypes associated with TCA and intermediary metabolic defects, outlining salient clinical features, genetic and molecular pathologies, medical management, and dynamic research areas that may affect future practice. © 2013 International Society of Nephrology.
first_indexed 2024-03-06T21:53:56Z
format Journal article
id oxford-uuid:4c3e87d1-b7f1-4710-8ca3-2f619e66f853
institution University of Oxford
language English
last_indexed 2024-03-06T21:53:56Z
publishDate 2013
record_format dspace
spelling oxford-uuid:4c3e87d1-b7f1-4710-8ca3-2f619e66f8532022-03-26T15:48:22ZRenal cell carcinoma: Translational aspects of metabolism and therapeutic consequencesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4c3e87d1-b7f1-4710-8ca3-2f619e66f853EnglishSymplectic Elements at Oxford2013Yang, OMaxwell, PPollard, PThe heterogeneity of renal cell carcinoma (RCC) poses a challenge for designing clinically applicable diagnostic and screening investigations, predictive and prognostic biomarkers, and targeted molecular therapies. Hereditary RCC syndromes harbor specific driver gene mutations, and their discoveries have provided unequivocal insight into the pathogenomic landscape of RCCs. These observed genetic aberrations correspond to a diverse range of dysplastic metabolic processes, including mutations in genes encoding tricarboxylic acid (TCA) cycle enzymes, defects in hypoxic and antioxidant signaling, and abnormalities in nutrient-sensing phosphorylation cascades. Medical management of RCC focused on understanding and correcting these metabolic abnormalities may refine current RCC screening, diagnosis, and treatment. This review describes RCC subtypes associated with TCA and intermediary metabolic defects, outlining salient clinical features, genetic and molecular pathologies, medical management, and dynamic research areas that may affect future practice. © 2013 International Society of Nephrology.
spellingShingle Yang, O
Maxwell, P
Pollard, P
Renal cell carcinoma: Translational aspects of metabolism and therapeutic consequences
title Renal cell carcinoma: Translational aspects of metabolism and therapeutic consequences
title_full Renal cell carcinoma: Translational aspects of metabolism and therapeutic consequences
title_fullStr Renal cell carcinoma: Translational aspects of metabolism and therapeutic consequences
title_full_unstemmed Renal cell carcinoma: Translational aspects of metabolism and therapeutic consequences
title_short Renal cell carcinoma: Translational aspects of metabolism and therapeutic consequences
title_sort renal cell carcinoma translational aspects of metabolism and therapeutic consequences
work_keys_str_mv AT yango renalcellcarcinomatranslationalaspectsofmetabolismandtherapeuticconsequences
AT maxwellp renalcellcarcinomatranslationalaspectsofmetabolismandtherapeuticconsequences
AT pollardp renalcellcarcinomatranslationalaspectsofmetabolismandtherapeuticconsequences